Investigational product for hypochondroplasia

· QED Therapeutics, a BridgeBio company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational product for hypochondroplasia, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Clinical Assessment Study in Children With Hypochondroplasia